Loading clinical trials...
Loading clinical trials...
Long-Term Treatment, Multicenter, Open-Label Study With SPP100 in Patients With Essential Hypertension
Conditions
Interventions
SPP100
Locations
1
Switzerland
Novartis Pharmaceuticals
Basel, Switzerland
Start Date
October 1, 2004
Last Updated
July 28, 2006
NCT02417740
NCT07073820
NCT07480265
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Novartis
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions